Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines

Abstract Background: Ovarian cancer is a significant cancer-related cause of death in women worldwide. The most used chemotherapeutic regimen is based on carboplatin (CBDCA). However, CBDCA resistance is the main obstacle to a better prognosis. An in vitro drug-resistant cell model would help in th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Viscarra,Tamara, Buchegger,Kurt, Jofre,Ignacio, Riquelme,Ismael, Zanella,Louise, Abanto,Michel, Parker,Alyssa C., Piccolo,Stephen R., Roa,Juan Carlos, Ili,Carmen, Brebi,Priscilla
Lenguaje:English
Publicado: Sociedad de Biología de Chile 2019
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100211
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0716-97602019000100211
record_format dspace
spelling oai:scielo:S0716-976020190001002112019-10-10Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell linesViscarra,TamaraBuchegger,KurtJofre,IgnacioRiquelme,IsmaelZanella,LouiseAbanto,MichelParker,Alyssa C.Piccolo,Stephen R.Roa,Juan CarlosIli,CarmenBrebi,Priscilla A2780 cell line Carboplatin Drug resistance Wnt/&#946;-catenin-signaling pathway Integrin signaling pathway Ovarian cancer Abstract Background: Ovarian cancer is a significant cancer-related cause of death in women worldwide. The most used chemotherapeutic regimen is based on carboplatin (CBDCA). However, CBDCA resistance is the main obstacle to a better prognosis. An in vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize cellular and molecular changes of induced CBDCA-resistant ovarian cancer cell line A2780. Methods: The cell selection strategy used in this study was a dose-per-pulse method using a concentration of 100 &#956;M for 2 h. Once 20 cycles of exposure to the drug were completed, the cell cultures showed a resistant phenotype. Then, the ovarian cancer cell line A2780 was grown with 100 &#956;M of CBDCA (CBDCA-resistant cells) or without CBDCA (parental cells). After, a drug sensitivity assay, morphological analyses, cell death assays and a RNA-seq analysis were performed in CBDCA-resistant A2780 cells. Results: Microscopy on both parental and CBDCA-resistant A2780 cells showed similar characteristics in morphology and F-actin distribution within cells. In cell-death assays, parental A2780 cells showed a significant increase in phosphatidylserine translocation and caspase-3/7 cleavage compared to CBDCA-resistant A2780 cells (P < 0.05 and P < 0.005, respectively). Cell viability in parental A2780 cells was significantly decreased compared to CBDCA-resistant A2780 cells (P < 0.0005). The RNA-seq analysis showed 156 differentially expressed genes (DEGs) associated mainly to molecular functions. Conclusion: CBDCA-resistant A2780 ovarian cancer cells is a reliable model of CBDCA resistance that shows several DEGs involved in molecular functions such as transmembrane activity, protein binding to cell surface receptor and catalytic activity. Also, we found that the Wnt/3-catenin and integrin signaling pathway are the main metabolic pathway dysregulated in CBDCA-resistant A2780 cells.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.52 20192019-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100211en10.1186/s40659-019-0220-0
institution Scielo Chile
collection Scielo Chile
language English
topic A2780 cell line
Carboplatin
Drug resistance
Wnt/&#946;-catenin-signaling pathway
Integrin signaling pathway
Ovarian cancer
spellingShingle A2780 cell line
Carboplatin
Drug resistance
Wnt/&#946;-catenin-signaling pathway
Integrin signaling pathway
Ovarian cancer
Viscarra,Tamara
Buchegger,Kurt
Jofre,Ignacio
Riquelme,Ismael
Zanella,Louise
Abanto,Michel
Parker,Alyssa C.
Piccolo,Stephen R.
Roa,Juan Carlos
Ili,Carmen
Brebi,Priscilla
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
description Abstract Background: Ovarian cancer is a significant cancer-related cause of death in women worldwide. The most used chemotherapeutic regimen is based on carboplatin (CBDCA). However, CBDCA resistance is the main obstacle to a better prognosis. An in vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize cellular and molecular changes of induced CBDCA-resistant ovarian cancer cell line A2780. Methods: The cell selection strategy used in this study was a dose-per-pulse method using a concentration of 100 &#956;M for 2 h. Once 20 cycles of exposure to the drug were completed, the cell cultures showed a resistant phenotype. Then, the ovarian cancer cell line A2780 was grown with 100 &#956;M of CBDCA (CBDCA-resistant cells) or without CBDCA (parental cells). After, a drug sensitivity assay, morphological analyses, cell death assays and a RNA-seq analysis were performed in CBDCA-resistant A2780 cells. Results: Microscopy on both parental and CBDCA-resistant A2780 cells showed similar characteristics in morphology and F-actin distribution within cells. In cell-death assays, parental A2780 cells showed a significant increase in phosphatidylserine translocation and caspase-3/7 cleavage compared to CBDCA-resistant A2780 cells (P < 0.05 and P < 0.005, respectively). Cell viability in parental A2780 cells was significantly decreased compared to CBDCA-resistant A2780 cells (P < 0.0005). The RNA-seq analysis showed 156 differentially expressed genes (DEGs) associated mainly to molecular functions. Conclusion: CBDCA-resistant A2780 ovarian cancer cells is a reliable model of CBDCA resistance that shows several DEGs involved in molecular functions such as transmembrane activity, protein binding to cell surface receptor and catalytic activity. Also, we found that the Wnt/3-catenin and integrin signaling pathway are the main metabolic pathway dysregulated in CBDCA-resistant A2780 cells.
author Viscarra,Tamara
Buchegger,Kurt
Jofre,Ignacio
Riquelme,Ismael
Zanella,Louise
Abanto,Michel
Parker,Alyssa C.
Piccolo,Stephen R.
Roa,Juan Carlos
Ili,Carmen
Brebi,Priscilla
author_facet Viscarra,Tamara
Buchegger,Kurt
Jofre,Ignacio
Riquelme,Ismael
Zanella,Louise
Abanto,Michel
Parker,Alyssa C.
Piccolo,Stephen R.
Roa,Juan Carlos
Ili,Carmen
Brebi,Priscilla
author_sort Viscarra,Tamara
title Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
title_short Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
title_full Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
title_fullStr Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
title_full_unstemmed Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
title_sort functional and transcriptomic characterization of carboplatin-resistant a2780 ovarian cancer cell lines
publisher Sociedad de Biología de Chile
publishDate 2019
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100211
work_keys_str_mv AT viscarratamara functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT bucheggerkurt functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT jofreignacio functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT riquelmeismael functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT zanellalouise functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT abantomichel functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT parkeralyssac functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT piccolostephenr functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT roajuancarlos functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT ilicarmen functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
AT brebipriscilla functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines
_version_ 1718441586238423040